Aurinia Pharmaceuticals (AUPH) Interest Coverage Ratio (2023 - 2026)

Aurinia Pharmaceuticals has reported Interest Coverage Ratio for 4 years, with the latest figure at 40.93 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio rose 99.9% year-over-year to 40.93; the trailing twelve-month figure through Mar 2026 stood at 29.12 (up 342.27% YoY), and the FY2025 full-year result was 24.23, up 2599.47% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 40.93, up from 31.75 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 40.93 in Q1 2026, with the low at 248.77 in Q2 2023.
• Historically, Interest Coverage Ratio has averaged 12.35 across 4 years, with a median of 4.23 in 2024.
• Annual changes were most pronounced in 2024 — Interest Coverage Ratio jumped 93.57% — and 2025, when it surged 2279.86%.
• Aurinia Pharmaceuticals' Interest Coverage Ratio stood at 22.65 in 2023, then jumped by 93.57% to 1.46 in 2024, then soared by 2279.86% to 31.75 in 2025, then increased by 28.93% to 40.93 in 2026.
• The last three Interest Coverage Ratio figures came in at 40.93 (Q1 2026), 31.75 (Q4 2025), and 27.07 (Q3 2025), per Business Quant data.